Abstract:LCL161, a novel Smac mimetic, is known to have anti-tumor activity and improve chemosensitivity in various cancers. However, the function and mechanisms of the combination of LCL161 and paclitaxel in non-small cell lung cancer (NSCLC) remain unknown. Cellular inhibitor of apoptotic protein 1 and 2 (cIAP1 and cIAP2) expression in NSCLC tissues and adjacent non-tumor tissues were assessed by immunohistochemistry. The correlations between cIAP1,2 expression and clinicopathological characteristics, prognosis were analyzed. Cell viability and apoptosis were measured by MTT assays and Flow cytometry. Western blot and co-immunoprecipitation assay were performed to measure the protein expression and interaction in NF-κB pathway. siRNA-mediated gene silencing and caspases activity assays were applied to demonstrate the role and mechanisms of cIAP1,2 and RIP1 in lung cancer cell apoptosis. Mouse xenograft NSCLC models were used in vivo to determine the therapeutic efficacy of LCL161 alone or in combination with paclitaxel. The expression of cIAP1 and cIAP2 in Non-small cell lung cancer (NSCLC) tumors was significantly higher than that in adjacent normal tissues. cIAP1 was highly expressed in patients with late TNM stage NSCLC and a poor prognosis. Positivity for cIAP1 and cIAP2 was an independent prognostic factor that indicated a poorer prognosis in NSCLC patients. LCL161, an IAP inhibitor, cooperated with paclitaxel to reduce cell viability and induce apoptosis in NSCLC cells. Molecular studies revealed that paclitaxel increased TNFα expression, thereby leading to the recruitment of various factors and the formation of the TRADD-TRAF2-RIP1-cIAP complex. LCL161 degraded cIAP1 and cIAP2, releasing RIP1 from the complex. Subsequently, RIP1 was stabilized and bound to caspase-8 and FADD, thereby forming the caspase-8/RIP1/FADD complex, which activated caspase-8, caspase-3 and ultimately lead to apoptosis. In nude mouse xenograft experiments, the combination of LCL161 and paclitaxel degraded cIAP1,2, activated caspase-3 and inhibited tumor growth with few toxic effects. Thus, LCL161 could be a useful agent for the treatment of NSCLC in combination with paclitaxel.

Involvement of Mitochondrial Permeability Transition Pore Opening in 7-Xylosyl-10-deacetylpaclitaxel-induced Apoptosis.

Activation of the Mitochondria-Driven Pathway of Apoptosis in Human PC-3 Prostate Cancer Cells by a Novel Hydrophilic Paclitaxel Derivative, 7-Xylosyl-10-deacetylpaclitaxel.

Sequence-Dependent Potentiation of Paclitaxel-Mediated Apoptosis in Human Leukemia Cells by Inhibitors of the Mitogen-Activated Protein Kinase Kinase/Mitogen-Activated Protein Kinase Pathway

The ClC-3 Chloride Channel Associated with Microtubules is a Target of Paclitaxel in Its Induced-Apoptosis

Possible mechanisms of paclitaxel-induced apoptosis.

Live morphological analysis of taxol-induced cytoplasmic vacuoliazation in human lung adenocarcinoma cells

Paclitaxel Induces the Apoptosis of Prostate Cancer Cells via ROS-Mediated HIF-1α Expression

The Possible Correlation Between Activation of NF-kappaB/IkappaB Pathway and the Susceptibility of Tumor Cells to Paclitaxel-Induced Apoptosis.

Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor

Paclitaxel Induce Apoptosis of Giant Cells Tumor of Bone Via TP53INP1 Signaling

Paclitaxel-Induced Apoptosis May Occur Without A Prior G(2)/M-Phase Arrest

The Relationship Between P38mapk and Apoptosis During Paclitaxel Resistance of Ovarian Cancer Cells

[Effects of Trichostatin A and Paclitaxel on Apoptosis and Mitochondrial Membrane Potential of Human Endometrial Carcinoma Ark2 Cells].

P2.03a-059 LCL161 Increases Paclitaxel-Induced Apoptosis by Degrading Ciap1 and Ciap2 in NSCLC: Topic: Clinical Trials

IκB Kinase Activation is Involved in Regulation of Paclitaxel-Induced Apoptosis in Human Tumor Cell Lines

Nuclear Factor-Kappab/ikappab Signaling Pathway May Contribute to the Mediation of Paclitaxel-Induced Apoptosis in Solid Tumor Cells.

Live Morphological Analysis of Taxol-Induced Cytoplasmic Vacuolization [corrected] in Human Lung Adenocarcinoma Cells.

The role of Survivin in the apoptosis of MCF-7 cells induced by paclitaxel

Targeted Inhibition of Transient Activation of the EGFR-mediated Cell Survival Pathway Enhances Paclitaxel-Induced Ovarian Cancer Cell Death

Taxol Induces Concentration-Dependent Apoptotic and Paraptosis-Like Cell Death in Human Lung Adenocarcinoma (Astc-a-1) Cells

P53-Dependent Apoptosis is Essential for the Antitumor Effect of Paclitaxel Response to DNA Damage in Papillary Thyroid Carcinoma.